The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Therapeutic Advances in Acute Myeloid Leukemia
Abstract
The choice of treatment approach and outcome in acute myeloid leukemia (AML) depends on the age of the patient. In younger patients, arbitrarily defined as being younger than 60 years, 70% to 80% enter complete disease remission with several anthracycline-based chemotherapy combinations. Consolidation with high-dose cytarabine or stem-cell transplantation in high-risk patients will restrict overall relapse to approximately 50%. A number of demographic features can predict the outcome of treatment including cytogenetics and an increasing list of molecular features (ie, FLT3, NPM1, MLL, WT1, CEBPalpha, EVI1). These are increasingly being used to direct postinduction therapy, but they are also molecular targets for a new generation of small molecule inhibitors that are in early development; however, randomized data have yet to emerge. In older patients who comprise the majority, which will increase with demographic change, the initial clinical decision to be made is whether the patient should receive an intensive or nonintensive approach. If the same anthracycline/cytarabine–based approach is deployed, the remission rate will be around 50%, but the risk of subsequent relapse is approximately 85% at 3 years. This difference from younger patients is explained partly by the ability of patients to tolerate effective therapy, and also the aggregation of several poor risk factors compared with the young. There remains a substantial proportion of patients older than 60 years who do not receive intensive chemotherapy. Their survival is approximately 4 months, but there is considerable interest in developing new treatments for this patient group, including novel nucleoside analogs and several other agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationSorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Self-citationCheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Self-citationCreutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Mayer, R. J., Davis, R. B., Schiffer, C. A., Berg, D. T., Powell, B. L., Schulman, P., Omura, G. A., Moore, J. O., McIntyre, O. R., & Frei, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311402 · Cited by 1,427
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Lowenberg, B., Downing, J. R., & Burnett, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411407 · Cited by 1,217
Self-citationJuliusson, G., Antunovic, P., Derolf, Å., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A., & Höglund, M. (2009) · Blood · doi:10.1182/blood-2008-07-172007 · Cited by 987
Sanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Self-citationAnthracycline Dose Intensification in Acute Myeloid Leukemia
Fernandez, H. F., Sun, Z., Yao, X., Litzow, M. R., Luger, S. M., Paietta, E. M., Racevskis, J., Dewald, G. W., Ketterling, R. P., Bennett, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904544 · Cited by 919
Koreth, J., Schlenk, R., Kopecky, K. J., Honda, S., Sierra, J., Djulbegovic, B. J., Wadleigh, M., DeAngelo, D. J., Stone, R. M., Sakamaki, H., et al. (2009) · JAMA · doi:10.1001/jama.2009.813 · Cited by 886
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P. J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.020 · Cited by 833
Self-citationHigh-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Löwenberg, B., Ossenkoppele, G. J., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Maertens, J., Jongen-Lavrencic, M., von Lilienfeld-Toal, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901409 · Cited by 828
Self-citationPaschka, P., Schlenk, R. F., Gaidzik, V. I., Habdank, M., Krönke, J., Bullinger, L., Späth, D., Kayser, S., Zucknick, M., Götze, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.3762 · Cited by 801
Marcucci, G., Maharry, K., Wu, Y.-Z., Radmacher, M. D., Mrózek, K., Margeson, D., Holland, K. B., Whitman, S. P., Becker, H., Schwind, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3730 · Cited by 763
Self-citationGale, R. E., Green, C., Allen, C., Mead, A. J., Burnett, A. K., Hills, R. K., & Linch, D. C. (2008) · Blood · doi:10.1182/blood-2007-08-109090 · Cited by 745
Self-citationBurnett, A. K., Hills, R. K., Milligan, D., Kjeldsen, L., Kell, J., Russell, N. H., Yin, J. A. L., Hunter, A., Goldstone, A. H., & Wheatley, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4310 · Cited by 657
Self-citationBurnett, A. K., Milligan, D., Prentice, A. G., Goldstone, A. H., McMullin, M. F., Hills, R. K., & Wheatley, K. (2007) · Cancer · doi:10.1002/cncr.22496 · Cited by 619
Self-citationKantarjian, H., O'Brien, S., Cortes, J., Giles, F., Faderl, S., Jabbour, E., Garcia‐Manero, G., Wierda, W., Pierce, S., Shan, J., et al. (2006) · Cancer · doi:10.1002/cncr.21723 · Cited by 610
Wouters, B. J., Löwenberg, B., Erpelinck-Verschueren, C. A. J., van Putten, W. L. J., Valk, P. J. M., & Delwel, R. (2009) · Blood · doi:10.1182/blood-2008-09-179895 · Cited by 566
Self-citationCornelissen, J. J., van Putten, W. L. J., Verdonck, L. F., Theobald, M., Jacky, E., Daenen, S. M. G., van Marwijk Kooy, M., Wijermans, P., Schouten, H., Huijgens, P. C., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025627 · Cited by 471
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]
Bishop, J., Matthews, J., Young, G., Szer, J., Gillett, A., Joshua, D., Bradstock, K., Enno, A., Wolf, M., & Fox, R. (1996) · Blood · doi:10.1182/blood.v87.5.1710.1710 · Cited by 458
Goldstone, A. H., Burnett, A. K., Wheatley, K., Smith, A. G., Hutchinson, R. M., & Clark, R. E. (2001) · Blood · doi:10.1182/blood.v98.5.1302 · Cited by 438
Self-citationWeick, J., Kopecky, K., Appelbaum, F., Head, D., Kingsbury, L., Balcerzak, S., Bickers, J., Hynes, H., Welborn, J., Simon, Sr., et al. (1996) · Blood · doi:10.1182/blood.v88.8.2841.bloodjournal8882841 · Cited by 411
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
Jongen-Lavrencic, M., Sun, S. M., Dijkstra, M. K., Valk, P. J. M., & Löwenberg, B. (2008) · Blood · doi:10.1182/blood-2008-01-133355 · Cited by 403
Self-citationAbbas, S., Lugthart, S., Kavelaars, F. G., Schelen, A., Koenders, J. E., Zeilemaker, A., van Putten, W. J. L., Rijneveld, A. W., Löwenberg, B., & Valk, P. J. M. (2010) · Blood · doi:10.1182/blood-2009-11-250878 · Cited by 393
Self-citationLöwenberg, B., Zittoun, R., Kerkhofs, H., Jehn, U., Abels, J., Debusscher, L., Cauchie, C., Peetermans, M., Solbu, G., & Suciu, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1268 · Cited by 384
Self-citationGratwohl, A., Stern, M., Brand, R., Apperley, J., Baldomero, H., de Witte, T., Dini, G., Rocha, V., Passweg, J., Sureda, A., et al. (2009) · Cancer · doi:10.1002/cncr.24531 · Cited by 379
Barjesteh van Waalwijk van Doorn-Khosrovani, S. (2003) · Blood · doi:10.1182/blood-2002-05-1459 · Cited by 355
Büchner, T., Berdel, W. E., Haferlach, C., Haferlach, T., Schnittger, S., Müller-Tidow, C., Braess, J., Spiekermann, K., Kienast, J., Staib, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4245 · Cited by 338
Hann, I. M., Stevens, R. F., Goldstone, A. H., Rees, J. K. H., Wheatley, K., Gray, R. G., & Burnett, A. K. (1997) · Blood · doi:10.1182/blood.v89.7.2311 · Cited by 297
Self-citationDufour, A., Schneider, F., Metzeler, K. H., Hoster, E., Schneider, S., Zellmeier, E., Benthaus, T., Sauerland, M.-C., Berdel, W. E., Büchner, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6010 · Cited by 293
The Outcomes and Costs of Acute Myeloid Leukemia Among the Elderly
Menzin, J., Lang, K., Earle, C. C., Kerney, D., & Mallick, R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1597 · Cited by 276
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group
Bishop, J., Lowenthal, R., Joshua, D., Matthews, J., Todd, D., Cobcroft, R., Whiteside, M., Kronenberg, H., Ma, D., & Dodds, A. (1990) · Blood · doi:10.1182/blood.v75.1.27.27 · Cited by 267
Paschka, P., Marcucci, G., Ruppert, A. S., Whitman, S. P., Mrózek, K., Maharry, K., Langer, C., Baldus, C. D., Zhao, W., Powell, B. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2058 · Cited by 258
Gröschel, S., Lugthart, S., Schlenk, R. F., Valk, P. J. M., Eiwen, K., Goudswaard, C., van Putten, W. J. L., Kayser, S., Verdonck, L. F., Lübbert, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0646 · Cited by 256
Self-citationLugthart, S., Gröschel, S., Beverloo, H. B., Kayser, S., Valk, P. J. M., van Zelderen-Bhola, S. L., Jan Ossenkoppele, G., Vellenga, E., van den Berg-de Ruiter, E., Schanz, U., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2771 · Cited by 256
Self-citationHegenbart, U., Niederwieser, D., Sandmaier, B. M., Maris, M. B., Shizuru, J. A., Greinix, H., Cordonnier, C., Rio, B., Gratwohl, A., Lange, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1765 · Cited by 251
Giles, F. J., Borthakur, G., Ravandi, F., Faderl, S., Verstovsek, S., Thomas, D., Wierda, W., Ferrajoli, A., Kornblau, S., Pierce, S., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06476.x · Cited by 248
Falini, B., Bolli, N., Liso, A., Martelli, M. P., Mannucci, R., Pileri, S., & Nicoletti, I. (2009) · Leukemia · doi:10.1038/leu.2009.124 · Cited by 239
Wheatley, K., Brookes, C. L., Howman, A. J., Goldstone, A. H., Milligan, D. W., Prentice, A. G., Moorman, A. V., Burnett, A. K., & on behalf of the United Kingdom National Cancer Research Institute Haematological Oncology Clinical Studies Group and Acute Myeloid Leukaemia Subgroup (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07663.x · Cited by 236
Self-citationBurnett, A. K., Hills, R. K., Milligan, D. W., Goldstone, A. H., Prentice, A. G., McMullin, M., Duncombe, A. S., Gibson, B. E. S., & Wheatley, K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9088 · Cited by 230
Self-citationWhitman, S. P., Maharry, K., Radmacher, M. D., Becker, H., Mrózek, K., Margeson, D., Holland, K. B., Wu, Y.-Z., Schwind, S., Metzeler, K. H., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283648 · Cited by 225
Self-citationBoissel, N., Nibourel, O., Renneville, A., Gardin, C., Reman, O., Contentin, N., Bordessoule, D., Pautas, C., de Revel, T., Quesnel, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2285 · Cited by 222
Pautas, C., Merabet, F., Thomas, X., Raffoux, E., Gardin, C., Corm, S., Bourhis, J.-H., Reman, O., Turlure, P., Contentin, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2652 · Cited by 218
Virappane, P., Gale, R., Hills, R., Kakkas, I., Summers, K., Stevens, J., Allen, C., Green, C., Quentmeier, H., Drexler, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0333 · Cited by 218
Self-citationStone, R. M., Berg, D. T., George, S. L., Dodge, R. K., Paciucci, P. A., Schulman, P. P., Lee, E. J., Moore, J. O., Powell, B. L., Baer, M. R., et al. (2001) · Blood · doi:10.1182/blood.v98.3.548 · Cited by 211
Schlenk, R. F., Dohner, K., Kneba, M., Gotze, K., Hartmann, F., del Valle, F., Kirchen, H., Koller, E., Fischer, J. T., Bullinger, L., et al. (2009) · Haematologica · doi:10.3324/haematol.13378 · Cited by 210
Löwenberg, B., Suciu, S., Archimbaud, E., Ossenkoppele, G. J., Verhoef, G. E. G., Vellenga, E., Wijermans, P., Berneman, Z. N., Dekker, A. W., Stryckmans, P. A., et al. (1997) · PubMed · doi:10.1182/blood.v90.8.2952 · Cited by 205
Self-citationLanger, C., Radmacher, M. D., Ruppert, A. S., Whitman, S. P., Paschka, P., Mrózek, K., Baldus, C. D., Vukosavljevic, T., Liu, C.-G., Ross, M. E., et al. (2008) · Blood · doi:10.1182/blood-2007-11-124958 · Cited by 192
Gardin, C., Turlure, P., Fagot, T., Thomas, X., Terre, C., Contentin, N., Raffoux, E., de Botton, S., Pautas, C., Reman, O., et al. (2007) · Blood · doi:10.1182/blood-2007-02-069666 · Cited by 174
ROUP, T. H. A. C. O. G. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00948.x · Cited by 162
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia
Bullinger, L., Ehrich, M., Döhner, K., Schlenk, R. F., Döhner, H., Nelson, M. R., & van den Boom, D. (2009) · Blood · doi:10.1182/blood-2009-03-211003 · Cited by 157
Metzeler, K. H., Dufour, A. M., Benthaus, T., Hummel, M., Sauerland, M., Heinecke, A., Berdel, W. E., Büchner, T., Wormann, B. J., Mansmann, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5328 · Cited by 154
Löwenberg, B., Beck, J., Graux, C., van Putten, W., Schouten, H. C., Verdonck, L. F., Ferrant, A., Sonneveld, P., Jongen‐Lavrencic, M., von Lilienfeld‐Toal, M., et al. (2010) · Blood · doi:10.1182/blood-2009-10-246470 · Cited by 145
Self-citationBurnett, A. K., Milligan, D. W., Goldstone, A. H., Prentice, A. G., McMullin, M., Dennis, M. W., Sellwood, E., Pallis, M., Russell, N. H., Hills, R. K., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07604.x · Cited by 139
Self-citationDamm, F., Heuser, M., Morgan, M. A., Yun, H., Großhennig, A., Göhring, G., Schlegelberger, B., Döhner, K., Ottmann, O. G., Lübbert, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0342 · Cited by 128
Burnett, A. K., Hills, R. K., Green, C. L., Jenkinson, S., Koo, K., Patel, Y., Guy, C., Gilkes, A., Milligan, D. W., Goldstone, A. H., et al. (2009) · Blood · doi:10.1182/blood-2009-08-236588 · Cited by 118
Self-citationPrognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal Cytogenetics
Gaidzik, V. I., & Döhner, K. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.005 · Cited by 110
Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia
Rao, A. V., Valk, P. J. M., Metzeler, K. H., Acharya, C. R., Tuchman, S. A., Stevenson, M. M., Rizzieri, D. A., Delwel, R., Buske, C., Bohlander, S. K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.2547 · Cited by 104
Self-citationAdvances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
Mrózek, K., Marcucci, G., Paschka, P., & Bloomfield, C. D. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831369df · Cited by 89
van der Holt, B., Breems, D. A., Beverloo, H. B., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06403.x · Cited by 69
Scholl, S., Theuer, C. M., Scheble, V. J., Kunert, C., Heller, A., Mügge, L., Fricke, H., Höffken, K., & Wedding, U. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.01019.x · Cited by 69
Santamaría, C., Chillón, C., García‐Sánz, R., Pérez, C., Caballero, M. D., Mateos, M., Ramos, F., de Coca, A. G., Alonso, J. M., Giraldo, P., et al. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0864-x · Cited by 45
Wieser, R., Scheideler, M., Hackl, H., Engelmann, M., Schneckenleithner, C., Hiden, K., Papak, C., Trajanoski, Z., Sill, H., & Fonatsch, C. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20740 · Cited by 23
Ficara, F., Murphy, M., Lin, M., & Cleary, M. L. (2007) · Blood · doi:10.1182/blood.v110.11.94.94 · Cited by 7
Cited by
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0441 · Cited by 912
Epigenetics in health and disease
Zhang, L., Lu, Q., & Chang, C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3449-2_1 · Cited by 689
Khwaja, A., Bjorkholm, M., Gale, R. E., Levine, R. L., Jordan, C. T., Ehninger, G., Bloomfield, C. D., Estey, E., Burnett, A., Cornelissen, J. J., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.10 · Cited by 592
Self-citationPretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Chonghaile, T. N., Sarosiek, K. A., Vo, T.-T., Ryan, J. A., Tammareddi, A., Moore, V. D. G., Deng, J., Anderson, K. C., Richardson, P., Tai, Y.-T., et al. (2011) · Science · doi:10.1126/science.1206727 · Cited by 585
How I treat extramedullary acute myeloid leukemia
Bakst, R. L., Tallman, M. S., Douer, D., & Yahalom, J. (2011) · Blood · doi:10.1182/blood-2011-04-347229 · Cited by 503
Metadata
- Authors
- Burnett, A., Wetzler, M., & Löwenberg, B.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-02-10
- Volume
- 29
- Issue
- 5
- Pages
- 487-494
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2112998845
- Cited by
- 787
- References
- 72
- FWCI
- 47.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.